UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002768
Receipt number R000003039
Scientific Title Effectiveness of pioglitanone hydrochloride on cerebral vasospasm after subarachnoid hemorrhage (SAH)
Date of disclosure of the study information 2009/12/01
Last modified on 2014/05/16 16:45:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of pioglitanone hydrochloride on cerebral vasospasm after subarachnoid hemorrhage (SAH)

Acronym

Effect of pioglitazone on vasospasm after SAH

Scientific Title

Effectiveness of pioglitanone hydrochloride on cerebral vasospasm after subarachnoid hemorrhage (SAH)

Scientific Title:Acronym

Effect of pioglitazone on vasospasm after SAH

Region

Japan


Condition

Condition

subarachnoid hemorrhage

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

effect of pioglitazone to vasospasm

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

functional prognosis (modified-Ranking Scale), evaluation of vasospasm by angiography, evaluation of cerebral infarction by CT or MRI

Key secondary outcomes

evaluation of adverse reaction


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

administration of pioglitazone

Interventions/Control_2

administration of placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

patient who was admitted with subarachnoid hemorrhage, blood sugar over 80 mg/dl at any time.

Key exclusion criteria

old person over 90 year-old, medicine hypersensitivity patient, pregnant woman or woman who has pregnancy possibly, hypoglycemia, person who was judged inadequat as patient by doctor.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidetoshi Kasuya

Organization

Tokyo Womens Medical University Medical Center East

Division name

Department of Neurosurgery

Zip code


Address

Nishiogu 2-1-10 Arakawa-ku Tokyo

TEL

03-3810-1111

Email

kasuya@dnh.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shiegru Tani

Organization

Tokyo Womens Medical University Medical Center East

Division name

Department of Neurosurgery

Zip code


Address

Nishiogu 2-1-10 Arakawa-ku Tokyo

TEL

03-3810-1111

Homepage URL

http://www.dnh.twmu.ac.jp

Email

stanine@dnh.twmu.ac.jp


Sponsor or person

Institute

Tokyo Womens Medical University Medical Center East

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学 東医療センター (東京都)


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2008 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 05 Month 01 Day

Last follow-up date

2013 Year 10 Month 31 Day

Date of closure to data entry

2013 Year 10 Month 31 Day

Date trial data considered complete

2013 Year 11 Month 30 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 11 Month 16 Day

Last modified on

2014 Year 05 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003039


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name